HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen Poor Selected Research

Stephen Poor Research Topics

Disease

7Macular Degeneration (Age-Related Maculopathy)
01/2023 - 01/2014
3Choroidal Neovascularization
01/2018 - 01/2014
1Doyne honeycomb retinal dystrophy
01/2023
1Vision Disorders (Hemeralopia)
01/2022
1Geographic Atrophy
01/2021
1Atrophy
01/2021
1Vascular Diseases (Vascular Disease)
01/2017
1Retinal Diseases
01/2017
1Corneal Neovascularization
01/2014

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 12/2015
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2018 - 12/2015
1Complement Factor B (Factor B)IBA
01/2023
1Therapeutic UsesIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2021
1chemotactic factor inactivatorIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1acrizanibIBA
01/2018
1Peptides (Polypeptides)IBA
01/2017
1Ranibizumab (Lucentis)FDA Link
01/2017
1afliberceptIBA
01/2017
1Retinaldehyde (Retinal)IBA
01/2017
1Myeloid Differentiation Factor 88IBA
01/2014
1Toll-Like Receptor 2IBA
01/2014

Therapy/Procedure

3Therapeutics
01/2018 - 12/2015
1Topical Administration
01/2018
1Intravitreal Injections
01/2018
1Lasers (Laser)
01/2014